Actively Recruiting
European Multicentre Study of Human Spinal Cord Injury
Led by University of Zurich · Updated on 2025-12-18
8000
Participants Needed
1
Research Sites
1165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Today there is accumulating evidence from animal experiments that regeneration can be induced after a spinal cord injury (SCI). Consequently in the near future, new therapeutic approaches to induce some regeneration will be included in the treatment of patients with SCI. The aim of this proposal is to provide the required clinical basis for the implementation of novel interventional therapies. The establishment of combined clinical, functional and neurophysiological measures for a qualitative and quantitative assessment of spinal cord function in patients with SCI at different stages during rehabilitation represents a basic requirement to monitor any significant effect of a new treatment. Therefore, several European Paraplegic Centres involved in the rehabilitation of acute traumatic SCI patients build up a close collaboration for standardised assessment. The aim is to get knowledge about the natural recovery after spinal cord lesion in a larger population of patients in the sense of a historical control group and to bring new standardised assessment tools to the clinical setting.
CONDITIONS
Official Title
European Multicentre Study of Human Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Single event traumatic or ischemic para- or tetraplegia
- First EMSCI assessment possible within the first 6 weeks after incidence
- Patient capable and willing of giving written informed consent
You will not qualify if you...
- Nontraumatic para- or tetraplegia such as discusprolaps, tumor, AV-malformation, or myelitis, except single event ischemic incidences
- Pre-known dementia or severe reduction of intelligence leading to reduced cooperation or inability to give consent
- Peripheral nerve lesions above the level of spinal cord lesion such as plexus brachialis impairment
- Pre-known polyneuropathy
- Severe craniocerebral injury
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Zurich
Zurich, Switzerland, 8008
Actively Recruiting
Research Team
A
Armin Curt, Prof., MD
CONTACT
M
Martin Schubert, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here